InspireMD, Inc.

InspireMD, Inc. develops and commercializes carotid stent systems used to treat carotid artery disease and help prevent stroke. The company is transitioning from a development-focused medical device business to a direct commercial model, with CGuard Prime as its lead product and a growing U.S. launch effort supported by manufacturing and distribution partners.

4 748,7 %

29,5 %

−543,3 %

+28,1 %

5.74

5.42

— InspireMD, Inc.
	%
Carotid stent systems	85% Implantable stent products used in carotid artery interventions to reduce stroke risk.
Commercialization and support services	10% Sales, training, market access and medical affairs support for product adoption.
Manufacturing and supply chain services	5% Third-party manufacturing and production transfer activities supporting product supply.

InspireMD sells primarily to hospitals, interventional physicians and vascular specialists that perform carotid...

Hospitals and surgical centersprimary
Buy carotid stent systems for use in inpatient and outpatient vascular procedures.
Interventional physicians and vascular specialistsprimary
Use and recommend the product based on clinical performance and ease of adoption.
Third-party payorssecondary
Influence utilization through coverage and reimbursement decisions for carotid procedures.
Commercial partners and distributorssecondary
May support U.S. launch, co-promotion and market access if direct commercialization is insufficient.

The company is headquartered in Miami, Florida, but its operational footprint remains tied to Israel and the U.S...

•Global headquarters in Miami, Florida
•U.S. commercialization build-out for CGuard Prime
•Manufacturing transfer to Aptyx in North Carolina
•Israeli operating exposure creates geopolitical risk
•U.S.-Israel trade policy can affect cost of goods and logistics

The core strategy is to establish CGuard Prime in the U.S. market through a direct sales organization, distribution...

U.S. commercialization of CGuard Primeshort-term

The U.S. market is the main growth opportunity and requires physician adoption, reimbursement and sales execution.

Manufacturing scale-up and supply continuityshort-term

Commercial success depends on reliable production and the ability to meet demand without disrupting quality or supply.

Partnership flexibilitymedium-term

If direct commercialization underperforms, collaboration can extend reach but may dilute economics.

The business is highly execution-dependent because revenue growth relies on successfully launching CGuard Prime and...

high

U.S. commercialization execution risk

The company is investing heavily in direct sales, training and distribution, but adoption may lag expectations.

Scope: CGuard Prime launch in the United States
Materiality: high

high

Manufacturing and supply chain dependence

Production is being transferred to a third-party manufacturer, creating quality, timing and capacity risk.

Scope: Aptyx contract manufacturing in North Carolina
Materiality: high

high

Geopolitical exposure to Israel

Conflict, sanctions or disruption in Israel could affect operations, logistics and profitability.

Scope: Israeli operations and supply chain
Materiality: high

high

Market acceptance and reimbursement risk

Physician adoption and third-party payor coverage determine procedure volumes and commercial success.

Scope: Carotid stent market
Materiality: high

medium

Trade policy and tariff risk

Tariffs on medical devices or Israel-linked imports could increase cost of goods sold and reduce pricing flexibility.

Scope: U.S.-Israel trade flows
Materiality: medium

Revenue recognition for device sales and partner arrangements

Can shift revenue between quarters and affect comparability

Inventory and manufacturing transfer accounting

Can affect gross margin and working capital

Commercialization expense recognition

Can suppress near-term operating results

Contingencies and product liability provisions

Can create earnings volatility if reserves change

InspireMD, Inc.

U.S. commercialization execution risk

Manufacturing and supply chain dependence

Geopolitical exposure to Israel

Market acceptance and reimbursement risk

Trade policy and tariff risk

Inspire Medical Systems, Inc.

INSPIRE VETERINARY PARTNERS, INC.

LifeMD, Inc.

INSMED Inc

CARLSMED, INC.

cbdMD, Inc.